The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans

OBJECTIVE: Fructose consumption has been implicated in the development of obesity and insulin resistance. Emerging evidence shows that fibroblast growth factor 21 (FGF21) has beneficial effects on glucose, lipid, and energy metabolism and may also mediate an adaptive response to fructose ingestion....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Metab
Autors principals: ter Horst, Kasper W., Gilijamse, Pim W., Demirkiran, Ahmet, van Wagensveld, Bart A., Ackermans, Mariette T., Verheij, Joanne, Romijn, Johannes A., Nieuwdorp, Max, Maratos-Flier, Eleftheria, Herman, Mark A., Serlie, Mireille J.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5681276/
https://ncbi.nlm.nih.gov/pubmed/29107295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2017.08.014
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars